Accelerate Diagnostics (AXDX) Short Interest Ratio & Short Volume $0.54 -0.01 (-1.10%) Closing price 04/15/2025 04:00 PM EasternExtended Trading$0.57 +0.03 (+4.81%) As of 04/15/2025 07:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Accelerate Diagnostics Short Interest DataAccelerate Diagnostics (AXDX) has a short interest of 359,000 shares, representing 2.34% of the float (the number of shares available for trading by the public). This marks a -15.63% decrease in short interest from the previous month. The short interest ratio (days to cover) is 8.3, indicating that it would take 8.3 days of the average trading volume of 59,611 shares to cover all short positions.Current Short Interest359,000 sharesPrevious Short Interest425,500 sharesChange Vs. Previous Month-15.63%Dollar Volume Sold Short$251,659.00Short Interest Ratio8.3 Days to CoverLast Record DateMarch 31, 2025Outstanding Shares25,210,000 sharesFloat Size15,340,000 sharesShort Percent of Float2.34%Today's Trading Volume36,408 sharesAverage Trading Volume59,611 sharesToday's Volume Vs. Average61% Short Selling Accelerate Diagnostics? Sign up to receive the latest short interest report for Accelerate Diagnostics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartAXDX Short Interest Over TimeAXDX Days to Cover Over TimeAXDX Percentage of Float Shorted Over Time Remove Ads Accelerate Diagnostics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/31/2025359,000 shares $251,659.00 -15.6%2.3%8.3 $0.70 3/15/2025425,500 shares $489,325.00 -3.2%2.8%9.3 $1.15 2/28/2025439,600 shares $474,768.00 -1.2%2.9%8.5 $1.08 2/15/2025444,900 shares $524,982.00 -4.0%2.9%8.3 $1.18 1/31/2025463,600 shares $625,860.00 +15.4%3.0%8 $1.35 1/15/2025401,900 shares $454,106.81 -1.2%2.6%6.1 $1.13 12/31/2024406,600 shares $487,920.00 -17.6%2.7%6.1 $1.20 12/15/2024493,500 shares $646,485.00 -6.0%3.2%7.6 $1.31 11/30/2024525,000 shares $871,500.00 0.0%3.6%8.7 $1.66 11/15/2024525,200 shares $971,620.00 +2.9%3.6%8.3 $1.85 Get the Latest News and Ratings for AXDX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Accelerate Diagnostics and its competitors with MarketBeat's FREE daily newsletter. 10/31/2024510,500 shares $980,160.00 +7.9%3.5%7.6 $1.92 10/15/2024473,100 shares $884,697.00 -0.8%3.4%7.7 $1.87 9/30/2024476,700 shares $815,157.00 +1.8%3.4%8.3 $1.71 9/15/2024468,400 shares $711,968.00 -12.6%3.4%8.9 $1.52 8/31/2024535,700 shares $1.07 million -2.8%3.9%10 $2.00 8/15/2024551,100 shares $920,337.00 -8.0%4.2%8.4 $1.67 7/31/2024599,300 shares $809,055.00 -1.4%4.9%8.7 $1.35 7/15/2024607,700 shares $698,855.00 -3.4%5.0%9.1 $1.15 6/30/2024629,000 shares $735,930.00 +14.0%5.2%9.1 $1.17 6/15/2024551,700 shares $744,795.00 +30.0%4.5%7.1 $1.35 5/31/2024424,400 shares $505,036.00 +9.6%3.5%5.6 $1.19 5/15/2024387,300 shares $356,316.00 +19.9%2.8%5.3 $0.92 4/30/2024322,900 shares $284,668.64 -13.6%2.5%5.2 $0.88 4/15/2024373,700 shares $326,987.50 +27.7%2.9%4.3 $0.88 3/31/2024292,600 shares $289,674.00 +1.7%2.3%2.2 $0.99 3/15/2024287,600 shares $273,220.00 -3.8%2.4%2.4 $0.95 2/29/2024299,000 shares $294,544.90 -13.9%2.5%2.5 $0.99 2/15/2024347,300 shares $413,287.00 -7.2%2.9%3 $1.19 1/31/2024374,200 shares $497,686.00 -16.5%4.2%3.4 $1.33 1/15/2024448,300 shares $1.66 million +9.9%5.8%5.3 $3.70 12/31/2023407,800 shares $1.60 million +3.6%5.3%14.1 $3.92 12/15/2023393,500 shares $1.81 million -10.0%5.1%13.9 $4.61 11/30/2023437,300 shares $1.89 million +11.9%5.8%17.6 $4.32 11/15/2023390,900 shares $2.07 million -2.4%5.2%23.1 $5.29 10/31/2023400,500 shares $2.40 million +11.8%5.4%23 $5.99 10/15/2023358,100 shares $2.11 million +11.5%4.8%17.9 $5.88 9/30/2023321,300 shares $1.85 million -8.9%4.3%13 $5.75 9/15/2023352,600 shares $2.16 million -15.2%4.7%15.3 $6.14 8/31/2023415,800 shares $2.91 million -1.2%9.3%15.6 $7.01 8/15/2023420,900 shares $2.98 million -3.8%9.4%15.1 $7.09REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). 7/31/2023437,400 shares $2.91 million +8.4%14.1%15.9 $6.66 7/15/2023403,500 shares $2.80 million +3.5%13.0%14.6 $6.95 6/30/2023390,000 shares $3.16 million -90.3%12.5%16.3 $8.10 6/15/20234,000,000 shares $3.17 million -7.6%12.9%14.9 $0.79 5/31/20234,330,000 shares $3.03 million +6.7%N/A16.7 $0.70 5/15/20234,060,000 shares $3.25 million -6.0%N/A13.4 $0.80 4/30/20234,320,000 shares $3.81 million -11.1%N/A14 $0.88 4/15/20234,860,000 shares $3.21 million +2.1%N/A16 $0.66 3/31/20234,760,000 shares $3.33 million -6.1%N/A16.2 $0.70 3/15/20235,070,000 shares $2.74 million +7.2%N/A16.6 $0.54 2/28/20234,730,000 shares $2.41 million +5.1%N/A15 $0.51 2/15/20234,500,000 shares $2.70 million +0.5%N/A15.5 $0.60 1/31/20234,480,000 shares $3.11 million +0.5%N/A15.8 $0.69 1/15/20234,460,000 shares $3.21 million -0.7%N/A13.3 $0.72 12/30/20224,490,000 shares $3.17 million +3.7%N/A13.6 $0.71 12/15/20224,330,000 shares $2.94 million -0.2%N/A14.6 $0.68 11/30/20224,340,000 shares $3.77 million +10.7%N/A12.8 $0.87 11/15/20223,920,000 shares $4.78 million -1.3%N/A8.4 $1.22 10/31/20223,970,000 shares $5.04 million -17.6%N/A4.3 $1.27 10/15/20224,820,000 shares $7.42 million -1.8%N/A5.1 $1.54 9/30/20224,910,000 shares $7.46 million -3.0%N/A5.3 $1.52 9/15/20225,060,000 shares $8.30 million -1.8%N/A4.6 $1.64 8/31/20225,150,000 shares $8.39 million -8.9%N/A4.1 $1.63 8/15/20225,650,000 shares $15.14 million +4.4%N/A3.9 $2.68 7/31/20225,410,000 shares $7.25 million +5.3%10.6%5.2 $1.34 7/15/20225,140,000 shares $7.30 million +5.3%10.1%4.7 $1.42 6/30/20224,880,000 shares $4.84 million -27.5%9.6%4.3 $0.99 6/15/20226,730,000 shares $6.25 million -3.4%13.2%5.9 $0.93 5/31/20226,970,000 shares $4.24 million +3.6%13.6%7.7 $0.61 5/15/20226,730,000 shares $4.64 million +0.3%14.3%12.7 $0.69 4/30/20226,710,000 shares $6.44 million -5.0%16.2%14.6 $0.96 4/15/20227,060,000 shares $7.27 million No Change17.0%17.1 $1.03 3/31/20227,060,000 shares $10.17 million +1.3%17.0%19.8 $1.44 3/15/20226,970,000 shares $11.85 million +1.5%17.3%22 $1.70 2/28/20226,870,000 shares $19.51 million -3.8%16.6%20.6 $2.84 2/15/20227,140,000 shares $20.13 million +2.0%17.3%18.7 $2.82 1/31/20227,000,000 shares $23.31 million +6.7%17.7%16.2 $3.33 1/15/20226,560,000 shares $26.90 million -1.4%16.5%15.7 $4.10 12/31/20216,650,000 shares $34.71 million -4.6%17.6%15.5 $5.22 12/15/20216,970,000 shares $31.64 million -2.7%18.5%15.2 $4.54 11/30/20217,160,000 shares $35.80 million -0.1%19.8%18 $5.00 11/15/20217,170,000 shares $47.97 million No Change19.1%21.8 $6.69 10/29/20217,170,000 shares $42.30 million -4.5%20.4%26.2 $5.90 10/15/20217,510,000 shares $49.79 million +0.8%21.4%29.8 $6.63 9/30/20217,450,000 shares $43.43 million -3.4%21.2%36.2 $5.83 9/15/20217,710,000 shares $46.11 million -2.4%22.5%49.5 $5.98 8/31/20217,900,000 shares $49.38 million -2.0%23.2%49.9 $6.25 8/13/20218,060,000 shares $48.12 million +0.1%23.6%47.6 $5.97 7/30/20218,050,000 shares $60.05 million +2.7%23.8%47.7 $7.46 7/15/20217,840,000 shares $51.35 million +0.9%23.2%42.7 $6.55REVEALED FREE: Our top 3 stocks to own in 2025 and beyond (Ad)Every time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (including the losers!). Click here for the names of our three top stocks to own this year (no purchase necessary). 6/30/20217,770,000 shares $62.63 million -2.0%23.0%41.2 $8.06 6/15/20217,930,000 shares $71.29 million -3.7%23.4%41.4 $8.99 5/28/20218,230,000 shares $62.47 million +3.4%24.2%41.3 $7.59 5/14/20217,960,000 shares $54.21 million -8.2%23.4%35 $6.81 4/30/20218,670,000 shares $64.24 million -0.2%25.4%33.9 $7.41 4/15/20218,690,000 shares $70.22 million -1.1%25.4%15.8 $8.08 3/31/20218,790,000 shares $71.46 million -0.8%26.7%15.4 $8.13 3/15/20218,860,000 shares $79.65 million +1.0%27.8%14.9 $8.99 2/26/20218,770,000 shares $90.24 million -8.5%27.5%14.4 $10.29 2/12/20219,580,000 shares $139.01 million -10.6%30.0%15.7 $14.51 1/29/202110,710,000 shares $110.63 million -19.9%34.8%18.1 $10.33 1/15/202113,370,000 shares $117.39 million -2.8%44.9%30.8 $8.78 12/31/202013,760,000 shares $102.51 million +0.2%46.3%52 $7.45 12/15/202013,740,000 shares $99.75 million -4.5%46.2%55.2 $7.26 11/30/202014,380,000 shares $116.77 million -3.4%48.3%56.4 $8.12 11/15/202014,880,000 shares $127.82 million -4.2%50.6%62 $8.59 10/30/202015,530,000 shares $147.22 million -0.6%52.8%57.8 $9.48 10/15/202015,630,000 shares $178.65 million -0.3%53.8%53.9 $11.43 9/30/202015,670,000 shares $167.04 million +5.0%53.9%49.3 $10.66 9/15/202014,920,000 shares $160.69 million +0.5%51.3%37.1 $10.77 8/31/202014,850,000 shares $180.87 million -3.3%51.1%31.5 $12.18 8/14/202015,350,000 shares $222.73 million -2.4%53.8%31.7 $14.51 7/31/202015,720,000 shares $228.41 million -0.3%55.1%34 $14.53 7/15/202015,760,000 shares $275.80 million -8.9%56.3%31.7 $17.50 6/30/202017,300,000 shares $249.99 million +1.7%61.8%33.8 $14.45 6/15/202017,010,000 shares $171.80 million +1.5%60.8%35.2 $10.10 5/29/202016,760,000 shares $140.78 million -0.3%55.1%34.6 $8.40 5/15/202016,810,000 shares $148.18 million +1.0%55.2%35.5 $8.82 4/30/202016,640,000 shares $181.54 million +5.5%52.9%37.2 $10.91 AXDX Short Interest - Frequently Asked Questions What is Accelerate Diagnostics' current short interest? Short interest is the volume of Accelerate Diagnostics shares that have been sold short but have not yet been closed out or covered. As of March 31st, investors have sold 359,000 shares of AXDX short. 2.34% of Accelerate Diagnostics' shares are currently sold short. Learn More on Accelerate Diagnostics' current short interest. What is a good short interest ratio for Accelerate Diagnostics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AXDX shares currently have a short interest ratio of 8.0. Learn More on Accelerate Diagnostics's short interest ratio. Which institutional investors are shorting Accelerate Diagnostics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Accelerate Diagnostics: Concourse Financial Group Securities Inc., and Wolverine Asset Management LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Accelerate Diagnostics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.34% of Accelerate Diagnostics' floating shares are currently sold short. Is Accelerate Diagnostics' short interest increasing or decreasing? Accelerate Diagnostics saw a drop in short interest during the month of March. As of March 31st, there was short interest totaling 359,000 shares, a drop of 15.6% from the previous total of 425,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Accelerate Diagnostics' float size? Accelerate Diagnostics currently has issued a total of 25,210,000 shares. Some of Accelerate Diagnostics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Accelerate Diagnostics currently has a public float of 15,340,000 shares. How does Accelerate Diagnostics' short interest compare to its competitors? 2.34% of Accelerate Diagnostics' shares are currently sold short. Here is how the short interest of companies in the industry of "measuring and control equipment" compare to Accelerate Diagnostics: Akoya Biosciences, Inc. (11.16%), Owlet, Inc. (4.08%), Singular Genomics Systems, Inc. (2.91%), Prenetics Global Limited (0.39%), Syntec Optics Holdings, Inc. (0.80%), Optex Systems Holdings, Inc (0.07%), MultiSensor AI Holdings, Inc. (3.10%), ClearSign Technologies Co. (0.55%), Data I/O Co. (0.14%), Astrotech Co. (0.14%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.93 billion), iShares 20+ Year Treasury Bond ETF ($9.31 billion), Strategy Incorporated ($8.42 billion), Charter Communications, Inc. ($4.52 billion), Apollo Global Management, Inc. ($4.26 billion), Super Micro Computer, Inc. ($3.98 billion), Capital One Financial Co. ($3.79 billion), TC Energy Co. ($3.43 billion), AppLovin Co. ($2.91 billion), and Schlumberger Limited ($2.89 billion). View all of the most shorted stocks. What does it mean to sell short Accelerate Diagnostics stock? Short selling AXDX is an investing strategy that aims to generate trading profit from Accelerate Diagnostics as its price is falling. AXDX shares are trading down $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Accelerate Diagnostics? A short squeeze for Accelerate Diagnostics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of AXDX, which in turn drives the price of the stock up even further. How often is Accelerate Diagnostics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AXDX, twice per month. The most recent reporting period available is March, 31 2025. More Short Interest Resources from MarketBeat Related Companies Akoya Biosciences Short Interest Data Owlet Short Interest Data Singular Genomics Systems Short Interest Data Prenetics Global Short Interest Data Syntec Optics Short Interest Data Optex Systems Short Interest Data MultiSensor AI Short Interest Data ClearSign Technologies Short Interest Data Data I/O Short Interest Data Astrotech Short Interest Data Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:AXDX) was last updated on 4/16/2025 by MarketBeat.com Staff From Our PartnersTwo Unmistakable Patterns Return…The signs suggest we're entering one of those rare periods now. That's why Central Banks are buying gold at...Golden Portfolio | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto’s crashing…but we’re still profitingMost traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....Crypto Swap Profits | SponsoredIs it CRAZY to still want reliable profits, despite this market?Larry Benedict, the acclaimed "Market Wizard," is calling an emergency briefing now... The same Larry who –...Brownstone Research | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredTariffs. Volatility. Fear. Here’s the Plan.Wall Street's panicking over tariffs. Volatility's back with a vengeance. If you've been glued to the he...Investors Alley | SponsoredThis story is about to go viralThis Story Could Go Viral as Soon as May 31 Quietly, towns like Shreveport, Louisiana and Fort Worth, Texas...Stansberry Research | SponsoredHow War with China Could Start in 128 DaysThe clock is ticking. Those who aren't prepared could lose everything. I've identified 43 investments we...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Accelerate Diagnostics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Accelerate Diagnostics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AXDX Stock Free AXDX Stock Alerts